Cell-Free DNA Isolation and Extraction Market - Global and Regional Analysis 2025-2035 | Research and Clinical Labs Boost Adoption of Cell-Free DNA Technologies

Rising cancer prevalence and government initiatives drive growth in the global cell-free DNA isolation and extraction market. Major players invest in new products, leveraging techniques like PCR and NGS for applications in oncology and more. The market expands across regions, fueled by academic and biotech demand.


Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis: Focus on Product, Platform, Techniques, Application, End User, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The use of cell-free DNA isolation and extraction kits, tubes, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives in the cell-free DNA isolation and extraction market.

The constant significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market.

Competitive Landscape

The global cell-free DNA isolation and extraction market comprise well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the isolation and extraction of cell-free DNA from different sample types.

Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2021-March 2025. The inclination of companies toward product launches suggests that the companies are involved in continuously bringing new products to the market to isolate cell-free DNA, which is primarily attributed to an increase in liquid biopsy studies and approval of several liquid biopsy assays by the regulatory agencies.

Key Questions Answered in the Report

  • How is cell-free DNA isolation and extraction revolutionizing oncology?
  • What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?
  • What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?
  • What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
  • What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies
  • What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
  • What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?
  • Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market?
  • Which companies are anticipated to be highly disruptive in the future, and why?

Key Topics Covered:

1. Markets Overview
1.1 Market Definition
1.2 Early Discovery and Application of cfDNA
1.3 Properties of cfDNA
1.4 Biological Role of cfDNA
1.5 Extraction of Circulating cfDNA
1.6 Application of Circulating cfDNA
1.7 Market Footprint and Growth Potential
1.8 Interruption in Research and Clinical Development and Commercial Operation
1.8.1 Research and Clinical Development
1.8.2 Commercial Operation
1.8.3 Navigating Crisis Recovery and Looking to the Future

2. Global Cell-Free DNA Isolation and Extraction Market: Industry Analysis
2.1 Overview
2.2 Legal Requirements and Framework in the U.S.
2.2.1 FDA Regulation
2.4 Legal Requirements and Framework in Asia-Pacific
2.4.1 China
2.4.2 Japan

3. Market Dynamics
3.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Opportunities

4. Competitive Landscape
4.1 Overview
4.2 Product Launch and Upgradations
4.3 Product Approvals and Business Funding
4.4 Synergistic Activities
4.5 Mergers and Acquisitions
4.6 Market Share Analysis (by Company), 2023 and 2024
4.7 Growth Share Analysis (by Company)

5. Global Cell-Free DNA Isolation and Extraction Market (by Product) $Million, 2023-2035
5.1 Overview
5.2 Cell-Free DNA Isolation and Extraction Kits
5.3 Cell-Free DNA Isolation and Extraction Tubes
5.4 Other Consumables

6. Global Cell-Free DNA Isolation and Extraction Market (by Platform), $ Million, 2023-2035
6.1 Overview
6.2 Next-Generation Sequencing (NGS)
6.3 Polymerase Chain Reaction (PCR)
6.4 Real-Time Polymerase Chain Reaction (RT-PCR)
6.5 Digital Polymerase Chain Reaction (dPCR)
6.6 Other Platforms

7. Global Cell-Free DNA Isolation and Extraction Market (by Techniques), $ Million, 2023-2035
7.1 Overview
7.2 Magnetic Beads-Based
7.3 Spin Column-Based
7.4 Other Techniques

8. Global Cell-Free DNA Isolation and Extraction Market (by Application), $ Million, 2023-2035
8.1 Overview
8.2 Non-Invasive Prenatal Testing (NIPT)
8.3 Oncology
8.3.1 Solid Tumor
8.3.2 Hematological Malignancies
8.4 Transplant Rejection
8.5 Other Applications

9. Global Cell-Free DNA Isolation and Extraction Market (by End User), $ Million, 2023-2035
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.3 Academic Research Institutes and Laboratories
9.4 Contract Research Organizations (CROs)
9.5 Clinical Diagnostic Centers
9.6 Other End Users

10. Global Cell-Free DNA Isolation and Extraction Market (by Region), $ Million, 2023-2035
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Denmark
10.3.7 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Singapore
10.4.7 Rest-of-Asia-Pacific (RoAPAC)
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest-of-Latin America (RoLA)
10.6 Rest-of-the-World

11. Company Profiles

  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Endress+Hauser AG
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Illumina, Inc.
  • Takara Bio Inc.
  • Aline Biosciences
  • EpiGentek Group, Inc.
  • Omega Bio-tek, Inc.
  • Promega Corporation
  • Streck, Inc.
  • AccuBioMed Co., Ltd.
  • AMSBIO
  • Covaris, Inc.
  • EntroGen, Inc.
  • NeoGeneStar LLC
  • Norgen Biotek Corp.
  • STRATEC SE
  • System Biosciences

For more information about this report visit https://www.researchandmarkets.com/r/qokcob

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

Recommended Reading